About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2025 Clareo Health. All rights reserved.

UNKNOWNPhase 2

Dornase Alpha for the Treatment of COVID-19

Determination of Dornase Alpha Effectiveness in COVID-19 Treatment

NCT04432987•Acibadem University

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

COVID-19

Interventions

Pulmozyme

Locations

1

Turkey (Türkiye)

Locations (1)

Acıbadem Altunizade Hospital

Istanbul, Turkey (Türkiye)

Key Dates

Start Date

May 25, 2020

Primary Completion Date

August 25, 2020

Completion Date

September 25, 2020

Last Updated

June 16, 2020

Related Studies

RECRUITINGPhase 1

A Safety and Immunogenicity Trial of Boost-2867 Vaccine, Via Intranasal and Intramuscular Routes

NCT07221162

Improving Post COVID-19 Syndrome With Hyperbaric Oxygen Treatments

NCT06082518

Post COVID-19 ConditionPost-COVID-19 Syndrome+4 more

RECRUITINGPhase 3

Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID

NCT06631287

Long COVIDSars-CoV-2 Infection+2 more

RECRUITINGPhase 3

A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease

NCT06679140

COVID-19 SARS-CoV-2 Infection

Dime La VerDAD: Verify, Debunk, and Disseminate

NCT06417762

InfluenzaCOVID-19+3 more

RECRUITINGPhase 1

Positron Emission Tomography (PET) Imaging of Thrombosis

NCT03830320

Atrial FibrillationCOVID-19+2 more

View all related studies

Contacts

Ercument Ovalı, MD

CONTACT

+905325729174 ercument.ovali@acibadem.com

Sponsors

Lead Sponsor

Acibadem University

Collaborators

The Scientific and Technological Research Council of Turkey

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 16, 2020Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions